ERT buys CRS adding respiratory diagnostics to offering
Cardiac monitoring and ePRO specialist ERT has added respiratory diagnostics and device manufacturing services to its offering with the acquisition of CareFusion Research Services (CRS) for $81m (€61m).
CRS, which was spun off from Cardinal Health in 2007, also provides pharmaceutical companies and contract research organizations with cardiac safety monitoring and electronic patient reported outcomes (ePRO).
eResearch Technology (ERT) CEO Michael McKelvey said the acquisition will help “clients in the clinical research industry with the ability to more efficiently capture, process and distribute clinical data during all phases of drug development.”
In wider terms the deal may indicate that the wave of consolidation among contract research organizations (CRO), demonstrated most recently by Charles River Laboratories bid for Wuxi, is starting to be mirrored by the ancillary research services industry.
